Tétu C, Dassa E, Boquet P L
Eur J Biochem. 1980 Jan;103(1):117-24. doi: 10.1111/j.1432-1033.1980.tb04295.x.
Different inhibitors of the energy metabolism have been assayed in Escherichia coli K12 for their ability to increase the level of guanosine 5'-diphosphate 3'-diphosphate (ppGpp) as a consequence of a restriction of its degradation. Inhibitors of the respiration and uncouplers of oxidative phosphorylations had effects similar to carbon-source-induced downshifts while the ATPase inhibitor dicyclohexylcarbodiimide was less efficient. The effects of dicyclohexylcarbodiimide and of the uncoupler carbonylcyanide p-fluoro methoxyphenylhydrazone (FCCP) on ppGpp degradation were compared in a drug-permeable envelope mutant. At concentrations of inhibitors sufficient to deplete the pool of ATP by 50%, only FCCP was able to block ppGpp degradation. Moreover, FCCP also inhibited ppGpp degradation in a ATPase-deficient strain growing on glucose as carbon source while, as expected, it did not change the level of ATP. It is concluded, according to Mitchell's chemiosmotic hypothesis, that, in vivo, the integrity of the transmembrane proton gradient rather than the ATP pool size is a prerequisite for the normal processing of the energy-dependent degradation of ppGpp.
在大肠杆菌K12中,对不同的能量代谢抑制剂进行了检测,以评估它们通过限制其二磷酸鸟苷3',5'-二磷酸(ppGpp)的降解来提高其水平的能力。呼吸抑制剂和氧化磷酸化解偶联剂的作用类似于碳源诱导的代谢下调,而ATP酶抑制剂二环己基碳二亚胺的效率较低。在一个药物可渗透的包膜突变体中,比较了二环己基碳二亚胺和解偶联剂对氟甲氧基苯腙羰基氰化物(FCCP)对ppGpp降解的影响。在抑制剂浓度足以使ATP池减少50%时,只有FCCP能够阻断ppGpp的降解。此外,FCCP还抑制了以葡萄糖作为碳源生长的ATP酶缺陷菌株中ppGpp的降解,正如预期的那样,它并没有改变ATP的水平。根据米切尔的化学渗透假说得出结论,在体内,跨膜质子梯度的完整性而非ATP池的大小是ppGpp能量依赖性降解正常进行的前提条件。